629 related articles for article (PubMed ID: 15515149)
1. Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery.
Li W; Huang Z; MacKay JA; Grube S; Szoka FC
J Gene Med; 2005 Jan; 7(1):67-79. PubMed ID: 15515149
[TBL] [Abstract][Full Text] [Related]
2. Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity.
Saravolac EG; Ludkovski O; Skirrow R; Ossanlou M; Zhang YP; Giesbrecht C; Thompson J; Thomas S; Stark H; Cullis PR; Scherrer P
J Drug Target; 2000; 7(6):423-37. PubMed ID: 10758913
[TBL] [Abstract][Full Text] [Related]
3. Low-pH-sensitive PEG-stabilized plasmid-lipid nanoparticles: preparation and characterization.
Choi JS; MacKay JA; Szoka FC
Bioconjug Chem; 2003; 14(2):420-9. PubMed ID: 12643753
[TBL] [Abstract][Full Text] [Related]
4. Stabilized plasmid-lipid particles: construction and characterization.
Wheeler JJ; Palmer L; Ossanlou M; MacLachlan I; Graham RW; Zhang YP; Hope MJ; Scherrer P; Cullis PR
Gene Ther; 1999 Feb; 6(2):271-81. PubMed ID: 10435112
[TBL] [Abstract][Full Text] [Related]
5. Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties.
Zhang YP; Sekirov L; Saravolac EG; Wheeler JJ; Tardi P; Clow K; Leng E; Sun R; Cullis PR; Scherrer P
Gene Ther; 1999 Aug; 6(8):1438-47. PubMed ID: 10467368
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight linear polyethylenimine-b-poly(ethylene glycol)-b-polyethylenimine triblock copolymers: synthesis, characterization, and in vitro gene transfer properties.
Zhong Z; Feijen J; Lok MC; Hennink WE; Christensen LV; Yockman JW; Kim YH; Kim SW
Biomacromolecules; 2005; 6(6):3440-8. PubMed ID: 16283777
[TBL] [Abstract][Full Text] [Related]
7. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice.
Merdan T; Kunath K; Petersen H; Bakowsky U; Voigt KH; Kopecek J; Kissel T
Bioconjug Chem; 2005; 16(4):785-92. PubMed ID: 16029019
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of polyethylene glycol (PEG)-modified cationic liposome-mediated gene deliveries: effects on serum stability and transfection efficiency.
Kim JK; Choi SH; Kim CO; Park JS; Ahn WS; Kim CK
J Pharm Pharmacol; 2003 Apr; 55(4):453-60. PubMed ID: 12803766
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery.
Heyes J; Hall K; Tailor V; Lenz R; MacLachlan I
J Control Release; 2006 May; 112(2):280-90. PubMed ID: 16603272
[TBL] [Abstract][Full Text] [Related]
10. pH-sensitive PEG lipids containing orthoester linkers: new potential tools for nonviral gene delivery.
Masson C; Garinot M; Mignet N; Wetzer B; Mailhe P; Scherman D; Bessodes M
J Control Release; 2004 Oct; 99(3):423-34. PubMed ID: 15451600
[TBL] [Abstract][Full Text] [Related]
11. Stabilized plasmid-lipid particles: pharmacokinetics and plasmid delivery to distal tumors following intravenous injection.
Monck MA; Mori A; Lee D; Tam P; Wheeler JJ; Cullis PR; Scherrer P
J Drug Target; 2000; 7(6):439-52. PubMed ID: 10758914
[TBL] [Abstract][Full Text] [Related]
12. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and gene delivery efficiency of novel oligo-arginine-linked PEG-lipids: effect of oligo-arginine length.
Furuhata M; Kawakami H; Toma K; Hattori Y; Maitani Y
Int J Pharm; 2006 Jun; 316(1-2):109-16. PubMed ID: 16600534
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of poly(amidoamine) dendron-bearing lipids with poly(ethylene glycol) grafts and their use for stabilization of nonviral gene vectors.
Takahashi T; Hirose J; Kojima C; Harada A; Kono K
Bioconjug Chem; 2007; 18(4):1163-9. PubMed ID: 17569497
[TBL] [Abstract][Full Text] [Related]
15. Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles.
Harvie P; Wong FM; Bally MB
J Pharm Sci; 2000 May; 89(5):652-63. PubMed ID: 10756331
[TBL] [Abstract][Full Text] [Related]
16. pH-responsive sulfonamide/PEI system for tumor specific gene delivery: an in vitro study.
Sethuraman VA; Na K; Bae YH
Biomacromolecules; 2006 Jan; 7(1):64-70. PubMed ID: 16398499
[TBL] [Abstract][Full Text] [Related]
17. Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier.
Choi YH; Liu F; Park JS; Kim SW
Bioconjug Chem; 1998; 9(6):708-18. PubMed ID: 9815164
[TBL] [Abstract][Full Text] [Related]
18. Development of novel poly(ethylene glycol)-based vehicles for gene delivery.
Schmieder AH; Grabski LE; Moore NM; Dempsey LA; Sakiyama-Elbert SE
Biotechnol Bioeng; 2007 Apr; 96(5):967-76. PubMed ID: 17039465
[TBL] [Abstract][Full Text] [Related]
19. Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes.
Mao S; Neu M; Germershaus O; Merkel O; Sitterberg J; Bakowsky U; Kissel T
Bioconjug Chem; 2006; 17(5):1209-18. PubMed ID: 16984130
[TBL] [Abstract][Full Text] [Related]
20. Increased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylation.
Hayes ME; Drummond DC; Hong K; Zheng WW; Khorosheva VA; Cohen JA; C O N; Park JW; Marks JD; Benz CC; Kirpotin DB
Mol Pharm; 2006; 3(6):726-36. PubMed ID: 17140260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
